Nurix Therapeutics (NRIX) EBITDA Margin (QoQ) (2019 - 2026)
Nurix Therapeutics (NRIX) EBITDA Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 43,771.00 |
| Feb 28, 2026 | -86,742.00 |
| Nov 30, 2025 | 54,562.00 |
| Aug 31, 2025 | -104,797.00 |
| May 31, 2025 | 23,099.00 |
| Feb 28, 2025 | 14,606.00 |
| Nov 30, 2024 | -5,289.00 |
| Aug 31, 2024 | -3,241.00 |
| May 31, 2024 | -12,877.00 |
| Feb 29, 2024 | 2,641.00 |
| Nov 30, 2023 | -8,239.00 |
| Aug 31, 2023 | -12,942.00 |
| May 31, 2023 | 25,135.00 |
| Feb 28, 2023 | 37,922.00 |
| Nov 30, 2022 | -28,489.00 |
| Aug 31, 2022 | -3,305.00 |
| May 31, 2022 | 4,439.00 |
| Feb 28, 2022 | 6,888.00 |
| Nov 30, 2021 | -23,031.00 |
| Aug 31, 2021 | 8,966.00 |